Ventricular arrhythmia: Role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs

Mount Sinai Journal of Medicine

Volumn 69, Issue 4, 2002, Pages 197-207

  Fischer, Avi ^a   Verma, Rajiv ^a   Gomes, Joseph A ^a   Mehta, Davendra ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antiarrhythmic agents; Implantable cardioverter defibrillator; Radiofrequency ablation; Sudden cardiac death; Ventricular tachycardia

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; ENCAINIDE; EQUINIDINE; FLECAINIDE; LIDOCAINE; MORACIZINE; POTASSIUM CHANNEL BLOCKING AGENT; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; TOCAINIDE; UNCLASSIFIED DRUG; VERAPAMIL;

CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; DISEASE CONTROL; DRUG MECHANISM; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; PATIENT SELECTION; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; SUDDEN DEATH;

ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; TACHYCARDIA, VENTRICULAR;

EID: 0036724666     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Sudden cardiac death
2. Sudden death in coronary artery disease: Acute ischemia versus myocardial substrate
3. Hybrid therapy for ventricular arrhythmia management
4. Antiarrhythmic drugs: From mechanisms to clinical practice
5. A classification of antiarrhythmic actions after a decade of new drugs
6. Mortality and morbidity in patients receiving encainide, flecainide, or placebo
7. ICD versus drugs in cardiac arrest survivors: Preliminary results of the Cardiac Arrest Study Hamburg
8. Overview of trends in the control of cardiac arrhythmia: Past and future
9. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
10. Long-term outcome with the automatic implantable cardioverter-defibrillator
11. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary
12. Comparison of results in two implantable defibrillators
13. Prevention of implantable-defibrillator shocks by treatment with sotalol
14. Effect of ventricular shock strength on cardiac hemodynamics
15. Effects of repeated electrical defibrillations on cardiac troponin I levels
16. Changes in cerebral oxygen uptake and cerebral electrical activity during defibrillation threshold testing
17. Cognitive dysfunction after ventricular fibrillation during implantable cardiovertor/defibrillator procedures is related to duration of the reperfusion interval
18. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: A longitudinal investigation
19. Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators
20. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction
21. Mechanisms of ventricular tachycardia
22. Catheter ablation of ventricular tachycardia related to coronary artery disease: The role of noncontact mapping
23. Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: Results and long-term follow-up
24. Strategies for catheter ablation of scar-related ventricular tachycardia
25. Ventricular activation during ventricular endocardial pacing. II. Role of pace-mapping to localize origin of ventricular tachycardia
26. Relationship between the 12-lead electrocardiogram during ventricular tachycardia and endocardial site of origin in patients with coronary artery disease
27. Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction
28. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction
29. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: Long-term success and the significance of inducible nonclinical arrhythmias
30. Day-to-day reproducibility of antiarrhythmic drug trials using programmed extrastimulus techniques for ventricular tachyarrhythmias associated with coronary artery disease
31. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias
32. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome
33. Concomitant device and drug therapy: Current trends, potential benefits, and adverse interactions
34. Effect of sotalol on ventricular fibrillation and defibrillation in humans
35. Interactions between implantable cardioverter-defibrillators and class III agents
36. Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator
37. Acute and chronic cycle length dependent increase in ventricular pacing threshold
38. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
39. Randomised trial of low-dose amiodarone in severe congestive heart failure
40. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia
41. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
42. Mortality in the survival with oral d-sotalol (SWORD) trial: Why did patients die?
43. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
44. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
45. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
46. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery Coronary Artery Bypass Graft (CABG) Patch Trial Investigators
47. A randomized study of the prevention of sudden death in patients with coronary artery disease
48. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study)
49. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
50. The AVID trial: Evidence based or randomized control trials - is the AVID study too late?
51. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone